Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.1.045

Development and Validation of an HPLC Method for the Pharmacokinetic Study of Dipyridamole in Human  

Cho, Hea-Young (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Kang, Hyun-Ah (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Moon, Jae-Dong (Medical School, Chonnam National University)
Choi, Hoo-Kyun (College of Pharmacy, Chosun University)
Lee, Yong-Bok (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University, Clinical Trial Center, Chonnam National University Hospital)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.1, 2006 , pp. 45-51 More about this Journal
Abstract
A rapid, selective and sensitive reversed-phase HPLC method for the determination of dipyridamole in human serum was developed, validated, and applied to the pharmacokinetic study of dipyridamole. Dipyridamole and internal standard, loxapine, were extracted from human serum by liquid-liquid extraction with diethyl ether and analyzed on a Nova Pak $C_{I8}$ column with the mobile phase of 40 mM ammonium acetate:methanol:acetonitrile (35:35:30)(v/v/v, pH 7.8). Detection wavelength of 280 nm and flow rate of 1.0 mL/min were fixed for the study. The assay robustness for the changes of mobile phase pH, organic solvent content, and flow rate was confirmed by $3^3$ factorial design using a fixed dipyridamole concentration (50 ng/mL) with respect to its peak area and retention time. And also, the ruggedness of this method was investigated at three different laboratories using same quality control (QC) samples. This method showed linear response over the concentration range of 2-2000 ng/mL with correlation coefficients greater than 0.999. The lower limit of quantification using 0.5 mL of serum was 2 ng/mL, which was sensitive enough for pharmacokinetic studies of dipyridamole. The overall accuracy of the quality control samples ranged from 103.94 to 105.86% for dipyridamole with overall precision (% C.V.) being 4.60-11.49%. The relative mean recovery of dipyridamole for human serum was 97.64%. Stability studies showed that dipyridamole was stable during storage, or during the assay procedure in human serum. The peak area and retention time of dipyridamole were not significantly affected by the changes of mobile phase pH, organic solvent content, and flow rate under the conditions studied. This method showed good ruggedness (within 15% C.V.) and was successfully used for the analysis of dipyridamole in human serum samples for the pharmacokinetic studies of orally administered Dimor tablet (75 mg as dipyridamole) at three different laboratories, demonstrating the suitability of the method.
Keywords
Dipyridamole; Human serum; Validation; Pharmacokinetics; HPLC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 식품의약청안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22)
2 J.M. Boeynaems, A. Van Coevorden and D. Demolle, Dipyridamole and vascular prostacyclin production, Biochem. Pharmacol., 35(17), 2897-2902 (1986)   DOI   ScienceOn
3 K.M. Wolfram and T.D. Bjornsson, High-performance liquid chromatographic analysis of dipyridamole in plasma and whole blood, J. Chromatogr., 183(1), 57-64 (1980)   DOI   ScienceOn
4 M. Berbri, J.L. Merlin and B. Weber, Sensitive determination of free and plasma protein-bound dipyridamole by high-performance liquid chromatography, J. Chromatogr., 565, 511-515 (1991)   DOI   ScienceOn
5 $WinNonlin^{TM}$ Users Guide Ver. 3.0, Pharsight Corp. Mountain View, CA, USA (1998-1999)
6 T.H. Muller, C.A. Su, H. Weisenberger, R. Brickl, G Nehmiz and W.G Eisert, Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo, Br. J. Clin. Pharmacol., 30(2), 179-186 (1990)   DOI   ScienceOn
7 Martindale, The complete drug reference, 32 editions 1999, p. 226 (1999)
8 C. Mahony, K.M. Wolfram, D.M. Cocchetto and T.D. Bjornsson, Dipyridamole kinetics, Clin. Pharmacol. Ther., 31(3), 330-380 (1982)   DOI   ScienceOn